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Chloride and fluid secretion by cultured human polycystic kidney cells.
Epithelial cells cultured from the renal cysts of patients with autosomal
dominant polycystic kidney disease (ADPKD) secrete fluid via a process
stimulated by adenosine 3'S-cyclic monophosphate (cAMP). We have
investigated the hypothesis that fluid secretion by these cells is dependent
on cAMP-mediated chloride secretion. Individual cultured ADPKD cells
were suspended within a polymerized collagen matrix and stimulated to
form cysts. Individual cultured cysts were placed in a chamber on the stage
of an inverted microscope equipped with epifluorescent and video analysis
attachments. The rate of fluid secretion, cell volume and changes in
intracellular CL were measured. In the absence of secretagogues, fluid
was absorbed from the cyst cavity (—2.36 0.64 nI/mm/cm2 inner surface
area). 8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) plus
3-isobutyl-1-methlyxanthine (IBMX) induced a rapid reversal in the net
movement of fluid to secretion (6.79 1.28 nI/mm/cm2). Bumetanide
reversibly reduced fluid secretion to 0.95 0.60 nI/mm/cm2. Cell volume
rapidly decreased by 7.5 0.9% with the initiation of secretion and
bumetanide caused an additional loss (4.2 1.0%). Furosemide had a
similar effect on forskolin-induced fluid secretion. Cellular chloride con-
centration was monitored with the use of the indicator, 6-methoxy-N-
ethylqumnolinium chloride (MEQ). Removal of Cl from the bath reduced
intracellular [Cl-] (MEQ fluorescence increased by 11.4 2.3%). In cysts
pretreated with furosemide to prevent CL entry, the application of
forskolin caused a decrease in CL concentration (MEQ fluorescence
increased by 9.3 2.6%). Using monolayers of cultured ADPKD cells,
grown on permeant supports, we compared the changes in short circuit
current (i) induced by forskolin in the presence and absence of external
CL. Forskolin increased 'Sc (from 8.9 2.7 to 10.6 2.7 AJcm2) in the
presence of CL, but did not significantly affect in its absence. These
data indicate that cultured ADPKD cells can direct fluid transport in
either the absorptive or the secretory direction, and that cAMP stimulates
secretion and this secretion is accompanied by a net loss of cell solute.
Inhibition of secretion by bumetanide or furosemide caused an additional
loss of cell solute, including Cl-. The ionic transepithelial current induced
by forskolin is dependent on the presence of CL. These data support the
thesis that chloride secretion drives fluid Secretion by cultured ADPKD
cells.
In autosomal dominant polycystic kidney disease (ADPKD),
the formation and growth of renal cysts are responsible for the
massive enlargement of the kidneys and contribute to the pro-
gressive deterioration of renal function. Cysts arise from the
proliferation of epithelial cells lining the nephron and the majority
of these cysts become disconnected from the renal segments from
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which they originate. Thus, the accumulation of fluid in these cysts
occurs by the transepithelial secretion of fluid into the cyst cavity
[1]. We have sought to identify the transport systems that drive
fluid secretion by this cystic epithelium. Studies using intact cysts
removed from ADPKD kidneys and monolayers of cells cultured
from ADPKD tissue have indicated that functional, ouabain-
sensitive, Na ,K -ATPase is located on the basolateral surface of
these cells [2, 3]. Recent immunohistological studies have con-
firmed the localization of this transporter to the basolateral
membrane [4, 5]. The Na4 ,K4-ATPase is responsible for estab-
lishing the chemical and electrical gradients that drive the sec-
ondary transport mechanisms involved in fluid secretion. Activa-
tors of adenylate cyclase and permeable cAMP analogues
stimulate these transport processes to secrete fluid, leading to the
enlargement of these cysts in vitro [3].
We have recently reported that the application of forskolin, an
adenylate cyclase agonist, to confluent monolayers of ADPKD
cells caused the net movement of fluid to reverse from absorption
to secretion [6]. The apical surface of these monolayers was
electrically negative with respect to the basolateral surface and a
positive short-circuit current (') from the apex to base was
measured. Forskolin hyperpolarized the cell layer and stimulated
Ic The changes in the electrical properties and direction of the
net fluid movement induced by forskolin point to the transepithe-
hal secretion of an anion. The addition of diphenylamine-2-
carboxylate (DPC), a CL channel blocker, to the apical surface of
these monolayers inhibited fluid secretion, depolarized the trans-
epithelial potential difference (V) and reduced L. Basolateral
application of bumetanide, an inhibitor of the Na/K/2Cl
cotransporter, also blocked fluid secretion, depolarized V1 and
decreased [61. These findings demonstrate that the secretion
of an anion is involved in forskolin-induced fluid secretion and
suggest the anion may be Cl. Electrogenic chloride secretion
mediated by cAMP has been demonstrated in several cultured
renal epithelial cell lines, including the Madin-Darby canine
kidney (MDCK), distal nephron cells of the Xenopus laevis (A6),
and the inner medullary collecting duct cell line, mIMCD-K2
[7—91. Rocha and Kudo [10] observed C1 secretion in isolated
and perfused rat IMCDs that involved a basohateral Na !K4I2CI
cotransporter and an apical conductance mediated by cAMP.
Based on our previous studies coupling electrogenic secretion of
an anion to the secretion of fluid [111, we propose that cAMP-
mediated Cl secretion is the cellular process that leads to the
accumulation of fluid within ADPKD cysts.
In the current study, we utilized microscopic cysts grown from
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cultured ADPKD cells suspended within a collagen matrix and
confluent monolayers of these cells grown on permeable supports
to identify the anion involved in fluid secretion and to further our
understanding of the mechanisms involved. Our results, in con-
junction with those previously reported, indicate that transcellular
C1 secretion drives fluid secretion by ADPKD epithelia. Chlo-
ride enters the cell via a basolateral Nat-Cl or Na47K/2 C1
cotransporter and exits across the apical membrane through
cAMP-dependent C1 channels.
Methods
Cell culture protocol
We harvested epithelial cells from the renal cysts of ADPKD
patients and grew primary cultures from these cells. This proce-
dure has been described in detail elsewhere [12, 13]. Steps were
taken to reduce the contamination of fibroblasts in the primary
cultures. First, during the dissection of the superficial cysts, we
manually removed the thin layer of fibroblast cells that line the
cyst. Second, the collected cyst walls were minced and treated with
1 mg/mI collagenase (Cooper Biochemical, Malvern, PA, USA)
for eight hours at 37°C. This has proven to be sufficient time for
the detachment of the epithelial cells from the connective tissue,
but relatively few fibroblasts are released, leading to an enriched
population of epithelial cells. Third, all studies were performed on
cells from the first and second cell passages, during which the
number of fibroblasts were relatively few.
ADPKD cells were maintained in a 1:1 mixture of Dulbecco's
modified Eagle's medium and Ham F12 (DME/F12: JRH Bio-
sciences, Lenexa, KS, USA) supplemented with 5% fetal bovine
serum (FBS; HyClone, Logan, UT, USA) and 100 lU/mi penicillin
G and 0.1 mg/mI streptomycin (PIS; Sigma Chemical, St. Louis,
MO, USA) on plastic until they were harvested by trypsinization.
For the formation of cultured cysts, ADPKD cells were suspended
in ice-cold type I collagen (Vitrogen; Collagen Corp., Palo Alto,
CA, USA) and placed in 24-well culture plates. Cells were
sparsely seeded at a density of 20,000 cells per well. Warming the
plates to 37°C caused polymerization of the collagen, trapping the
cells within a collagen matrix. A defined media (DME/Ham's F12,
P/S, 5 jig/ml insulin, 5 jig/mI transferrin, and 5 ng/ml selenite
(ITS), 5 X 10 M hydrocortisone, and 5 X i0 M triiodothyro-
nine; Sigma Chemical Co.) containing 5 jiM forskolin and 25
nglml EGF were placed above the gelled matrix. Forskolin and
EGF stimulated individual cells to form cysts (Fig. 1A). After five
to seven days of growth, the secretagogues were removed and the
cysts were incubated for 24 hours in defined media. For each
experiment, an individual cyst was dissected from the gel and
placed in a thermostatted lucite perfusion chamber mounted on
the stage of an inverted microscope (Nikon, Garden City, NY,
USA). Spherical cysts with an uniform cell thickness were se-
lected. A thin layer of collagen surrounding the cyst was allowed
to remain to maintain cell polarity and to assist in holding the cyst
in the chamber with suction pipets (Fig. 1B). The cyst was
superfused with a modified Ringer's solution containing (in mM);
147 Na , 119 Cl, 20 HC01, 6 alanine, 5 K, 5 acetate, 5
glucose, 4 lactate, 2.5 HPO4 , 1.2 Mg2, 1,2 SO42, 1 citrate, 0.5
butyric acid and 14 raffinose, equilibrated with 3% CO2/97% 02.
In experiments in which a chloride-free Ringer's solution was
used, CY was replaced with the molar equivalent of cyclamate or
nitrate, as noted.
Measurement of fluid secretion rate and cell volume
The methods for measuring cyst cavity volume and the cell
volume were previously described in detail [11, 14]. Fluid secre-
tion was determined by the rate of change in the cyst cavity
volume. The cross sectional image of the cyst was periodically
recorded on videotape with a video camera mounted on the side
port of the microscope. To reduce possible photo damage to the
cells and bleaching of fluorophors, a computer (486/33 MHz) was
used to control the tungsten illuminating microscope lamp and
video cassette recorder, limiting the exposure of light to periods of
five seconds. The interval between measurements varied from one
to five minutes depending on the experimental protocol. The fluid
volume within the cyst cavity and the volume of the cell layer
lining the cavity were determined using video analysis (JAVA;
Jandel, Corte Madera, CA, USA). The fluid secretion rate was
calculated from the slope of the regression line for the cavity
volume versus time and was expressed as units of volume per time
per unit inner surface area of the cyst (Fig. 3). Changes in cell
volume were expressed as the ratio of the measured volume to the
volume in the control period (V/V0).
Analysis of intracellular chloride
Intracellular chloride was monitored using the fluorescent
chloride indicator, 6-methoxy-N-ethylquinolinium chloride
(MEQ; Molecular Probes, Eugene, OR, USA). Like other dyes
used to measure chloride, MEQ is quenched by collision with
halide ions (relative sensitivity is C1 > Br > I) [151. There-
fore, an increase in the fluorescence signal represents a decrease
in the concentration of intracellular C1. A calibration curve for
MEQ in glass capillary tubes containing media of various Cl
concentrations is displayed in Figure 2. This curve indicates that
MEQ is less sensitive to Cl— concentration changes as the
concentration approaches that usually found in the plasma. The
use of MEQ, rather than previously developed Cl indicators,
offers two advantages. First, the quenching of MEQ fluorescence
by Cl is more effective, and second, MEQ can be loaded
noninvasively into the cells by reducing the compound with
sodium borohydrate to 6-methoxy-N-ethyl-1,2-dihydroquinoline
(diH-MEQ). This procedure masks a positively charged nitrogen
rendering the compound lipophilic and insensitive to halides [151.
We loaded the cells of the cultured cysts with 50 to 100 jiM
diH-MEQ for 10 to 15 minutes prior to the experiment. Oxidative
enzymes within the cell converted diH-MEQ to MEQ, trapping
the chloride-sensitive form within the cytosol. The media contain-
ing the dye was removed and the 0.5 ml chamber was perfused at
a rate of 3 mi/mm with media lacking the dye for at least 10
minutes before measurements were made. This allowed time for
complete oxidation of the dye within the cell. The perfusion of the
chamber also continually removed dye that may have leaked from
the cells. A 75 watt xenon arc lamp provided the source of exciting
light. The light passed through a 330 nm bandpass filter (Omega
Optical Inc., Brattleboro, VT, USA) and a 1.5 optical density filter
(to reduce the light intensity). A 400 nm dichroic mirror directed
the light through a 40 X microscope objective to the tissue. The
emitted light from the dye in the cells of the cyst passed back
through the objective and dichroic mirror to a 550 dichroic mirror
contained within a multi-image module. Wavelengths below 550
nm were directed to the photometer (Nikon) where a 445 nm
bandpass filter (Chroma Technology Corp.) selected only the light
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Fig. 1. A. Multiple cysts clonally grown from
individual ADPKD cells suspended within a
collagen matrix. The largest cyst has a diameter
of 80 microns. The bar located at the bottom
right denotes 100 microns. B. Video image of a
cultured ADPKD cyst dissected from the
matrix. The cyst is surrounded by a thin rim of
collagen. The outer diameter of this cyst is
approximately 140 microns. The bar located at
the lower left indicates 10 microns.
emitted by the dye for measurement. The output of the photom- As described previously [11], a pinhole, placed in the emitted light
eter was monitored by the computer through an analog-digital pathway, allowed light from the cells at the edge of the cyst to pass
board (Data Translation mc, Marlboro, MA, USA). The corn- to the photometer, but excluded light that may have originated
puter opened a shutter in the light path to excite the tissue for a from dye leaking into the cyst chamber. The chamber media
period of 120 rnsec and averaged the output from the photometer contained an undetectable amount of dye. Fractional changes in
at I msec intervals for the last 100 msec that the shutter was open. MEQ fluorescence were recorded to overcome the complications
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Fig. 2. Calibration of the chloride indicator 6-methoxy-N-ethylquinolinium
chloride, MEQ. Fluorescence intensity of the dye in glass capillary tubes
containing solutions of various chloride concentrations was measured and
recorded in arbitrary photometer units. MEQ fluorescence is quenched by
chloride.
of varying baseline levels of dye and dye loss from the cell
throughout the experiment. Calibrating the fluorescence of MEQ
to a molar concentration of cellular chloride could not be done
readily. The dye leaked from the cells throughout the experiment
and the calibration procedures require access to the fluid on both
sides of the cell layer.
Ussing chamber experiments
Confluent monolayers of ADPKD cells were grown on collagen
coated permeable supports. Their electrical properties in the
presence and absence of Cl in the bathing media were com-
pared. For each experiment, a pair of monolayers receiving the
same growth conditions were mounted in standard Ussing cham-
bers and the electrical measurements were made as previously
described [6]. The control monolayer was bathed in normal
Ringer's media containing 119 mivi Cl (the same composition as
described above). The experimental monolayer was bathed in a
chloride-free solution containing cyclamate. A voltage clamp
apparatus (JWT Engineering, Overland Park, KS, USA) was used
to record V1,,, the current necessary to clamp the voltage to zero
(I) and the transepithelial resistance (Rte). The average of the
last two measurements in each period (5 mm interval) were used
for comparison between pairs of monolayers and among each
group.
Statistical analysis
Sequential measurements of the rate of fluid secretion and the
cell volume were compared by repeated measures ANOVA and
the Student-Newman-Keuls multiple comparison post-test. In
evaluating the statistical significance of the changes in MEQ
fluorescence, the peak measurement in each period was compared
to the average of the last two values in the previous period using
the paired Student's t-test.
Results
Cultured cysts of ADPKD cells
Primary cultures of ADPKD cells were dispersed arid sus-
pended within a polymerized collagen matrix. The addition of
forskolin and EGF to the media above the collagen stimulated
Forskolin + IBMX
—40 —20 0 20 40 60
Time, minutes
Fig. 3. Effect of 10 p.Mforskolin and 100 pM JBMX on fluid transport and
cell layer volume in an individualADPKD cyst. Chloride concentration was
119 mM. A. The points record the changes in cavity volume in relation to
time before and after the addition of forskolin + IBMX to the bath. The
solid lines are the regression lines for the points in each of the two periods.
The aberrant point immediately following the solution change was ex-
cluded from the regression. Rates of fluid movement were calculated from
the slope of the regression lines and corrected for the inner surface area
of the cyst. See text for these values. B. The points indicate the corre-
sponding changes in cell volume.
these cells to form cysts, confirming previous results [16]. Figure
1A displays several cysts of different sizes suspended within the
polymerized matrix. Only spherical cysts with uniform cell thick-
ness were selected for use. An image of an isolated cultured
ADPKD cyst, captured by our video analysis system is displayed in
Figure lB.
Fluid transport and cell volume
The upper panel of Figure 3 displays a typical change in net
fluid movement induced by forskolin and IBMX. Each point of
the graph represents the volume of the cyst cavity measured by
video analysis. The slope of the regression line for the points in
each period indicates the rate of fluid movement during that
period. The cyst absorbed fluid at a steady rate of —1.73 nI/mini
cm2 inner surface area during the 60-minute control period. The
addition of forskolin (10 /.LM) and IBMX (100 J.LM) to the bathing
media rapidly reversed the net movement of fluid to secretion
(2.88 nI/mm/cm2). This rate of fluid secretion was maintained for
at least 60 minutes.
The initiation of fluid secretion was accompanied by a rapid loss
of cell volume (Fig. 3B). The volume of the cell layer (0.757 nI)
decreased by 6.2% (0.047 nI) within the first five minutes of
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Fig. 4. Effect of 100 M bumetanide on fluid
secretion and cell volume following the induction
of secretion by 100 pi 8-Br-cAMP + 100 .M
IBMX Chloride concentration was 1119 mM.
The secretion rates for the four periods are:
—0.154, 6.494, 0.038 and 7.032 nI/mm/cm2. A.
Cavity volume. B. Cell layer volume. Cell0 10 20 30 40 50 60 volume is expressed as the ratio of volume at
any time to the volume at zero time (V/V0).
V0 = 8.03 x 102 nI/cm2 outer surface area.
forskolin stimulation and an additional 4.5% during the remain-
der of the 60 minute period. The volume of the fluid within the
cavity measured 1.38 ni and increased by 0.034 nl at five minutes.
Thus the initial loss of cell volume was primarily across the apical
membrane (72%), although volume was lost across the basolateral
membrane as well (28%). After 20 minutes of forskolin stimula-
tion, the increase in cavity volume exceeded the loss in cell volume
by 31% and at 60 minutes by 61%.
Effect of bumetanide
Basolateral application of humetanide and furosemide, inhibi-
tors of the Na *IK+12C1 cotransporter, typically block cAMP-
mediated fluid secretion in secretory epithelia [17-191. We previ-
ously reported that arginine vasopressin (AVP)-induced fluid
secretion by cultured cysts of MDCK cells was inhibited by
basolateral application of bumetanide [11]. Thus, we tested the
effect of bumetanide on cAMP-activated fluid secretion by cul-
tured ADPKD cysts. The experiment was divided into four
20-minute periods (Fig. 4): the first was a control period; in the
second period the cAMP agonists, 8-Br-cAMP and IBMX were
administered; in the third period, the cyst was exposed to bumet-
anide plus the agonists; and the last was a recovery period in
which the cyst was exposed to only the cAMP agonists. The upper
panel of Figure 4 displays the cavity volume of an individual cyst.
The rates of fluid movement for each period are noted in the
legend. Elevating intracellular cAMP with the membrane perme-
able analogue, 8-Br-cAMP (100 LM), and IBMX (100 lM)
induced fluid secretion in the cultured ADPKD cyst. The addition
of 100 jIM bumetanide to the basolateral surface of the cyst
abolished the secretion of fluid. Fluid secretion resumed in the
fourth period following the removal of bumetanide.
The lower panel of Figure 4 presents the changes in cell volume
that occurred in each period. The values are presented as the ratio
of the cell layer volume at any time to that of the volume at the
end of the control period (VIV0). A rapid initial loss of cell
volume (4.1%) accompanied the activation of fluid secretion. Cell
volume decreased an additional 2.9% with the subsequent addi-
tion of bumetanide. Removal of bumetanide from the basolateral
media allowed the cell volume to recover and fluid secretion to
resume.
Figure 5 summarizes the results of 12 such experiments. In the
upper panel, the bars represent the rate of fluid movement during
each of the 20 minute periods as noted. Positive values indicate
the secretion of fluid from the basolateral media to the cyst cavity
and negative values indicate fluid absorption. In the control
period, ADPKD cysts absorbed fluid from the cavity at an average
rate of —2.36 0.64 nI/mm/cm2 (P < 0.005). The addition of
8-Br-cAMP and IBMX caused the fluid movement to reverse
from absorption to secretion (6.79 1.28 nl/min/cm2, P < 0.001).
Basolateral application of bumetanide reduced fluid secretion to
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Fig. 5. Summaiy of the effect of /00 p.M bumetanide on cAMP-stimulated
fluid Secretion (A) and cell volume (B). Chloride Concentration was 119 mM.
Values are means SE (N = 12). * Comparison with the preceding period,
P < 0.001.
0.95 0.60 ni/mm/cm2 (Period 2 vs. Period 3, P < 0.001). This
value does not differ from zero. The inhibitory effect of bumet-
anide was reversible; fluid secretion almost completely recovered
when bumetanide was removed. The bars in the lower panel
represent relative changes in cell volume (V/V0). Stimulation
with 8-Br-cAMP caused a rapid loss of cell volume of 7.5 0.9%,
P < 0.001. Cell volume was further reduced by 4.2 1.0% (P <
0.001) following the application of bumetanide. With the removal
of bumetanide, the cell volume recovered to 90.9 0.9% of
control.
Measurements of intracellular chloride
In six of the above experiments, the intracellular CY - indicator,
MEQ, was used to monitor changes in CL concentration. There
was no noticeable change in the concentration of CL with the
addition of cAMP. The rapid loss of cell volume without a change
in intracellular chloride ([Cl ]) indicates that CL as well as water
were lost from the cell during the initiation of fluid secretion by
cAMP. Intracellular CL could not be monitored during the
bumetanide period since the ring structure of bumetanide fluo-
resces at the same wavelength used to record MEQ fluorescence
[201.
To test the ability of MEQ to record changes in [Cl - 1 in this
preparation, we removed Cl from the Ringer's solution bathing
Table 1. Effect of forskolin in the presence and absence of
extracellular chloride on individual cultured cysts of ADPKD cells
Period
Forskolin +
IBMX
Bath [C1]
mi
Fluid secretion
ni min1 cm
1 — 119 —2.10 1.03
2 — 0 —9.95 2.67*
3 + 0 —12.75 2.51
4 — 0 —9.20 1.72
5 — 119 0.22 0.58*
6 + 119 S.4O±O.6lh
Values are means SE; N = 4. Concentrations are forskolin (10 p.M)
and 3-isobutyl-1-methylxanthine (IBMX, 100 p.M). In the zero chloride
media, CL was replaced with 119 m cyclamate. Each period is 20
minutes. Secretion rates were determined by video analysis (see text).
a Comparison to the previous period, P < 0.05b Comparison to forskolin + IBMX in 0 CL, P < 0.05
the basolateral surface of the cysts. Chloride was replaced with
either cyclamate (4 experiments) or with nitrate (3 experiments).
A typical response to Ci removal on MEQ fluorescence (record-
ed in arbitrary photometer units) is displayed in Figure 6.
Switching the bathing media to a chloride-free Ringer's solution
increased the fluorescence from 228 to a peak value of 268 units.
The average peak increase in MEQ fluorescence in the seven
experiments was 11.4 2.3% (P < 0.005), reflecting a fall in the
concentration of cell Cl.
In the four experiments in which cyclamate was used as a Cl —
substitute, we tested the effect of forskolin on fluid secretion in the
absence and in the presence of normal CL by individual cysts
(Table 1). Cysts bathed in normal CL absorbed fluid in the
control period and increased the rate of absorption when CL was
removed, This increase in absorption is probably due to the
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Fig. 6. Effect of the removal of bath Cl— on MEQ fluorescence intensity in
a cultured ADPKD cyst. Bath C1 (119 mM) was replaced with 119 mM
cyclamate. The dashed vertical line indicates the time of C1 removal. An
* increase in fluorescence indicates a fall in [Cl].
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Furosemide, another common inhibitor of the Na/K/2CL
cotransporter, is structurally different from bumetanide and does
not fluoresce [20]. Therefore, we used furosemide in experiments
in which we monitored intracellular [Cl—] with MEQ. To confirm
that furosemide also inhibited cAMP-mediated fluid secretion in
ADPKD epithelia, we tested the effect of 500 M furosemide on
forskolin-induced fluid secretion. In a series of four experiments,
the application of furosemide to the basolateral surface of the
cysts, reduced fluid secretion from 2.31 0.48 to —0.39 0.1
ni/mm/cm2 (P < 0.05).
In the experiment illustrated in Figure 7, furosemide was
administered to a cultured ADPKD cyst, while monitoring intra-
cellular [CL]. Furosemide produced a small transient increase in
MEQ fluorescence (fall in [Cl]). The subsequent addition of 10
iM forskolin and 100 .tM IBMX to the furosemide-treated cyst
induced a large increase in the fluorescence of MEQ, indicating a
decrease in the concentration of cell CL. Removing furosemide,
forskolin, and IBMX allowed the MEQ fluorescence to return to
the level extrapolated from the slope of dye loss in the control
period. To minimize the problem of dye loss, the changes in MEQ
fluorescence were calculated as a ratio of the peak fluorescence in
each experimental period to that of the last two measurements in
the previous period. The peak changes in MEQ fluorescence
following administration of furosemide and the subsequent addi-
tion of the cAMP agonists in seven experiments are displayed in
Figure 8. The first bar indicates the peak increase in fluorescence
following the application of 100 or 500 M furosemide. In six of
the seven experiments there was an increase in the MEQ fluores-
cence with furosemide, although this increase was not significant.
However, a loss of cell volume of 3.6 0.8% (P < 0.005) also
occurred. These two measurements indicate that the amount of
CL in the cell declined. The second bar indicates the peak
increase in fluorescence with the subsequent addition of forskolin
and IBMX. Forskolin induced a 9.3 2.6% (P < 0.02) peak
increase in MEQ fluorescence at an average time of 5.0 2.6
minutes, indicating a fall in cell CL concentration.
Electrical properties of ADPKE) monolayers
To confirm that CL is the secreted anion, we examined the
effect of removing external Cl on the changes in electrical
properties of ADPKD monolayers induced by forskolin. This
technique allowed us to remove Cl from the media on both sides
of the cell layer, thereby preserving the absence of a transepithe-
hal chemical gradient for CL. Seven pairs of monolayers were
mounted in Ussing chambers. Each pair of monolayers were
grown in the same culture plate under identical conditions. One
was bathed in normal CI Ringer's solution and the other in a
chloride-free Ringer's solution containing cyclamate. The control
'Sc was significantly reduced in the monolayers exposed to zero
Cl (Table 2). In the control monolayers, forskolin increased 'sc
and reduced Rte. Basolateral application of humetanide abolished
this increase in as previously demonstrated [6]. In monolayers
bathed in zero CL, the increase in 'Sc with forskolin was not
significant and there was no effect of bumetanide.
Forskolin + IBMX
500 1M Furosemide
220
200
180
160
140
—5 0 5 10 15 20 25 30 35
Time, minutes
Fig. 7. Effect of 500 p.M furosemide and subsequent addition of 10 p.M
forskolin + 100 p.M IBMX on MEQ fluorescence. Chloride concentration
was 119 msi. An increase in fluorescence reflects a decrease in [CL]1.
passive movement of CL from the cavity to the bath driven by the
chemical gradient for CL across the cell layer. In the absence of
bath CL, the rate of fluid absorption increased with forskolin in
all four experiments, although the change did not reach a level of
statistical significance. After the cysts were returned to normal
CL and allowed to equilibrate for 20 minutes, no net movement
of fluid occurred. The application of forskolin stimulated the
secretion of fluid in the presence of bath CL. The forskolin
response in normal CL was not tested in the nitrate experiments,
thus these experiments are not included in Table 1.
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+
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Fig. 8. Summaiy of the effects of 100 to 500 p..w Jhrosemide and the
subsequent additions of 10 p.w forskolin + 100 p.M IBMX on MEQ
fluorescence. Chloride concentration was 119 m. Fluorescence is ex-
pressed as the ratio of the peak fluorescence to the fluorescence at the end
of the previous period. An increase in the ratio above one indicates a loss
of intracellular [CLI. N = 7. *Comparison to a ratio value of 1.00, P <
0.02.
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Table 2. Effect of forskolin on the electrical properties of ADPKD
monolayers in the presence and absence of chloride
'ScpA cm Vin V Rohms cm
Normal Cl -
Control 8.9 2.7 —2.4 0.6 223 24
Forskolin 10.6 2.7" —2.0 0.4 162 17"
Bumet. + Forsk. 5.4 2.1 —1.4 0.4" 194 18'
0 CV
Control 1.7 04h —0.6 oF' 210 62
Forskolin 3.1 0.9i —0.9 O.3 181 50
Bumet. + Forsk. 3.5 0.8 —1.0 0.3" 206 61
Values are means SE; N = 7. Normal chloride concentration was 119
mM. In the zero chloride media, CV was replaced with 119mM cyclamate.
Forskolin (10 M) and bumetanide (100 jsM) were added to the basolat-
eral surface of the monolayers. Abbreviations are: I, short-circuit; V,.,
transepithelial voltage; transepithelial resistance.
Comparison to previous period, P < 0.005
Comparison to normal CL, P < 0.05
Discussion
involvement of Na, K-A TPase
In autosomal dominant polycystic kidney disease the majority
of the renal cysts lack tubular connections, and thus the accumu-
lation of fluid within the cyst cavity occurs by transepithelial
secretion of fluid [1]. Intact cysts that were excised from ADPKD
kidneys have been shown to secrete fluid in response to forskolin
[3]. The application of ouabain, an inhibitor of the Na,K-
ATPase, to the basolateral surface of these cysts blocked the
forskolin-stimulated fluid secretion. However, the addition of
ouabain to the cavity fluid of these cysts had no effect on fluid
secretion [2]. Monolayers of cells cultured from the ADPKD cysts
also secrete fluid in response to forskolin, and, when mounted in
Ussing chambers, exhibit an increase in l in response to the
secretagogues. The fluid secretion and increase in were
blocked by basolateral application of ouabain, but not by apical
application [2]. These results verify that functional Na,K -
ATPase units are located in the hasolateral membrane and
establish the chemical and electrical gradients that drive the
secondary transport mechanisms involved in fluid secretion.
Anion secretion drives fluid secretion
We recently reported that ADPKD monolayers absorb fluid
and exhibit an apical-negative V1 and a positive 'Sc (apex to base)
in the absence of adenylate cyclase agonists [6]. Forskolin applied
to these monolayers reversed the direction of fluid transport from
absorption to secretion, hyperpolarized V1 and increased 'sc
The direction of fluid movement coupled with the concomitant
changes in and V, indicated that fluid secretion is driven by
the transepithelial secretion of an anion. The application of the
CL channel blocker, DPC, to the apical surface of these mono-
layers depolarized reduced and blocked fluid secretion.
Bumetanide also depolarized V1, reduced 'sc and blocked fluid
secretion when applied to the basolateral side. However, the
basolateral application of an inhibitor of the CL/HC03 ex-
changer, 4,4'diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS),
did not affect the electrical changes induced by forskolin. We
compared these findings to those obtained with monolayers of
MDCK cells, since the mechanisms for fluid secretion by MDCK
cells have been well documented [9, ii, 21]. Forskolin also
stimulated fluid secretion with similar changes in and Isc in
the MDCK monolayers. DPC and bumetanide produced the same
inhibitory effect on forskolin-stimulated fluid secretion and elec-
trical changes in these monolayers as they did in ADPKD
monolayers. Based on these results, we concluded that forskolin-
stimulated fluid secretion is driven by the active transepithelial
secretion of an anion. The inhibition of secretion by apical DPC
and basolateral bumetanide, led us to hypothesize that fluid
secretion is driven by Cl secretion involving mechanisms similar
to those in secretory epithelia [16, 22].
Fluid secretion by cultured ADPKD cysts
In the current study, we investigated the mechanism involved in
fluid secretion in cultured cysts formed from individual ADPKD
cells, utilizing techniques developed for the study of fluid secre-
tion by cultured MDCK cysts [11, 14]. These techniques enabled
us to accurately measure fluid secretion in periods of minutes
rather than hours or days, while simultaneously monitoring cell
volume and intracellular [Cl ]. Cultured ADPKD cysts absorbed
fluid in the absence of cAMP agonists and secreted fluid when
stimulated by forskolin or 8-Br-cAMP (Figs. 3 and 5). In the 12
cysts presented in Figure 5, the net movement of fluid reversed
from absorption to secretion within 3.5 1.0 minutes (P < 0.02)
after the addition of the secretagogue. This rapid reversal of the
direction of fluid movement suggests that the transporters in-
volved in fluid secretion are already in or near the appropriate cell
membranes. Evidently, the expression of new carrier or channel
proteins are not required.
The rate of fluid secretion during the 20 minutes following
cAMP addition was 0.41 0.08 J/cm2/hr (converted from
nl/min/cm2, Fig. 5). This rate is quite comparable to the rates of
fluid secretion measured in 24 hour periods in monolayers of
ADPKD cells (0.60 0.03 .d/cm2/hr, [6]) and in intact excised
ADPKD cysts (0.19 0.03 jsl/cm2/hr, [2]). This similarity in rates
of fluid secretion among the three different experimental proto-
cols indicates that: (1) secretion by cysts clonally derived from a
solitary cultured cell does not differ substantially from that of
monolayers cultured from I X 106 cells; (2) the rate of fluid
secretion measured in the initial 20 minutes in the cultured cysts
are maintained for at least 24 hours in the monolayers; and (3)
that both of the cultured preparations preserve the secretory
ability of the tissue from which they are derived.
Cell volume and chloride changes during fluid secretion
An initial rapid loss of cell volume (7.5%) accompanied the
cAMP-dependent activation of fluid secretion. We calculated that
72% of the volume lost from the cell in the first five minutes of
stimulation was lost across the apical membrane. This initial loss
of solute and fluid into the cavity indicates that the activation of
an apical efflux pathway for solute is the first step in fluid
secretion. The concentration of intracellular CL remained un-
changed during the loss of cell volume, suggesting that Cl efflux
paralleled the loss of water. We have previously reported that the
cAMP agonist, AVP, caused a reduction in cell volume in cultured
cysts of MDCK cells as it initiated fluid secretion [11].
In the cultured ADPKD cysts, basolateral application of bu-
metanide reversibly inhibited forskolin-stimulated fluid secretion.
Cell volume decreased an additional 4.2% with the administration
of bumetanide. The decrease in cell volume and inhibition of fluid
secretion indicates that a basolateral cotransport mechanism
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normally adds solute to the cell during cAMP-stimulated fluid
secretion. Furosemide exerted similar effects on forskolin-stimu-
lated fluid secretion. In cysts pretreated with furosemide, the
addition of forskolin caused a fall in intracellular C1 concentra-
tion measured by MEQ fluorescence (Figs. 7 and 8). The decrease
in [Cl] suggests that furosemide prevented the basolateral entry
of CL during forskolin-activated CL efflux. We reported previ-
ously that bumetanide inhibited fluid secretion induced by AVP
and caused a similar decrease in cell volume in cultured cysts of
MDCK cells [11].
In cultured ADPKD cysts, the removal of Cl from the bathing
media decreased intracellular [CL] and prevented forskolin-
stimulated fluid secretion. In all four experiments the removal of
CL from the bath increased the rate of fluid absorption. We
attribute the increase in absorption to a net effiux of CL from the
cyst cavity caused by the large transepithelial gradient for CL
across the cell layer. The subsequent addition of forskolin did not
statistically alter the rate of fluid movement, although we regis-
tered an increase in fluid absorption in all four experiments. The
activation of apical CL channels by forskolin, allowing CL to
enter the cell across the apical membrane in response to the
altered electrochemical gradients could possibly account for the
increased absorption.
To confirm that CL is the anion involved in cAMP-stimulated
secretion, ADPKD monolayers were exposed to forskolin in the
presence and absence of bath Cl. In the experimental group,
both sides of the monolayer were bathed in a Ringer's solution
lacking CL. In these monolayers, the increase in 'Sc with
forskolin was not significant and insensitive to basolateral bumet-
anide. The insensitivity to bumetanide must be interpreted with
caution because Cl - may be required for the binding of bumet-
anide to the Na/K72CL cotransporter [181. The increase in
that occurred in some of these monolayers may be due to HC01
secretion. As discussed below, the cystic fibrosis transmembrane
conductance regulator (CFTR) is present in the apical membrane
of ADPKD cells. CFTR has been shown to be permeable to
HCO3 [23] with a CLIHCO3 permeability ratio of 3.8 1241.
Possible mechanisms involved in secretion
Application of DPC to the apical surface of ADPKD monolay-
ers inhibited forskolin-stimulated anion secretion and fluid secre-
tion, suggesting that fluid secretion is dependent on an apical
anion conductance [6]. In the current study, forskolin induced a
loss of cell volume into the cyst cavity and produced a decrease in
intracellular [Cl -] in furosemide-treated cysts. These two results
suggest that the anion conductance involved in secretion may be
a Cl - channel. The small conductance CL channel associated
with cystic fibrosis, CFTR, has been shown to be abundantly
expressed in the human nephron [25, 261 and has recently been
localized to the apical membrane of cultured ADPKD cells
exposed to forskolin [5, 27]. High concentrations of DPC inhibit
the CFTR chloride current and has been used to block CL
secretion in epithelia that express CFTR [28]. Another inhibitor
of anion transport, DIDS, blocks Cl 7HC01 exchange and some
types of epithelial CL channels [29, 30], but is unable to block the
CL conductance of CFTR [28]. We found that apical application
of DIDS did not affect forskolin-stiniulated anion secretion in
ADPKD monolayers (unpublished observations, R. Mangoo-
Karim and L. P. Sullivan). Similar results were obtained by
Hanaoka and associates [31], using primary cultures of ADPKD
epithelia. They found that 8-(4-chlorophenylthio)-adenosine
3',5'-cyclic monophosphate (CPT-cAMP) and forskolin increased
CL currents recorded by whole cell patch clamp. This cAMP-
activated Cl conductance was insensitive to DIDS and inhibited
by DPC. These immunohistochemical and functional studies
provide strong evidence that CFTR is the efflux pathway for the
transepithelial secretion of CL.
Bumetanide and furosemide have been shown to block Cl -
secretion in several secretory epithelia such as cells of the trachea
[19], intestine [321, and the shark rectal gland [18], when applied
to the basolateral membrane. Bumetanide is believed to inhibit
the Na4/K/2CL cotransporter by competitively binding to one
of the Cl sites on the external surface of the membrane [18]. In
ADPKD and MDCK monolayers, bumetanide inhibited forsko-
un-stimulated anion and fluid secretion [6]; it also inhibited fluid
secretion and reduced cell volume in cultured ADPKD and
MDCK cultured cysts [11]. These data suggest that the Na/K/
2CL cotransporter may be the basolateral mechanism transport-
ing CL into the cell during fluid secretion induced by cAMP
agonists.
Grantham and coworkers reported that 10 /kM forskolin in-
creased cAMP content by 236% in monolayers of ADPKD cells
[21. In the current study, as in a previous study [61, forskolin, an
adenylate cyclase agonist and 8-Br-cAMP, a permeable analogue
of cAMP, were used to elevate intracellular cAMP. These agents
had similar effects on fluid secretion, cell volume, and intracellular
[CL] in cultured cysts and on the electrical properties of mono-
layers [6]. Together these data confirm that the effect of forskolin
on fluid secretion is mediated through the elevation of cAMP
within the cell.
Fluid absorption by ADPKD cells
Monolayers of cultured ADPKD cells absorbed fluid in the
absence of cAMP agonists and secreted fluid when these agonists
were present [2, 6]. We found that these monolayers exhibited an
apical-negative and a positive I (apex to base) in the
absence of cAMP agonists. The direction of fluid movement and
the electrical orientation of these monolayers suggest that fluid
absorption is due to the transcellular absorption of a cation,
possibly Na [61.
The previous studies using monolayers and excised intact cysts
unquestionably demonstrated the ability of cystic epithelia to
direct fluid transport in both the absorptive and secretory direc-
tion; however, the question of cellular heterogeneity in these
preparations made it difficult to determine if single cells have this
capability or if two or more cell types were involved. In this study,
the cysts that resulted from a sparse seeding of cells in a collagen
matrix developed by clonal growth from a single cell [33]. Thus the
cells in each cyst are homogeneous. These cultured cysts absorbed
fluid in the absence of cAMP agonists and secreted fluid when
stimulated by forskolin or 8-Br-cAMP (Figs. 3 and 5). This finding
confirms that the transport processes involved in fluid absorption
and those responsible for secretion reside in the same cell.
The results of these experiments indicate that cultured ADPKD
cells utilize mechanisms to secrete fluid that may be found in
other secretory epithelia. The data do not exclude the possibility
that additional secretory mechanisms may be utilized by ADPKD
cysts. The results also do not pinpoint any specific difference that
may account for the dominance of fluid secretion in the cystic
epithelium as compared to normal tubular epithelium.
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In summary, these results demonstrate that cultured ADPKD
epithelial cells absorb fluid in the absence of cAMP agonists and
secrete fluid when these agonists are present. The loss of cell
volume following initiation of fluid secretion indicated that acti-
vation of an apical efflux pathway is the initial step in that process.
The additional loss of cell volume that occurred with inhibition of
secretion by furosemide and bumetanide strongly suggests that a
basolateral cotransport process adds solute to the cell during
secretion. The fall in cell Cl— concentration that followed the
addition of forskolin to the cysts pretreated with furosemide and
the lack of a response to forskolin by monolayers bathed in a
chloride-free media are strong additions to the evidence that C1
secretion drives fluid secretion by ADPKD epithelia.
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